Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 51Neoplasms 34Colorectal Neoplasms 23Lung Neoplasms 17Prostatic Neoplasms 16Melanoma 15Neoplastic Cells, Circulating 13Pancreatic Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Ovarian Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Papillomavirus Infections 7Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Lymphoma, Follicular 6Lymphoma 6Hematologic Neoplasms 6Uveal Melanoma 5Sarcoma 5Head and Neck Neoplasms 5Glioma 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Disease 4COVID-19 4

Interventions

enzalutamide 4Abiraterone Acetate 2radium Ra 223 dichloride 1dactolisib 1abiraterone 1VT-464 1Prednisone 1NVP-BKM120 1Flutamide 1Crizotinib 1Control Groups 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Castration-resistant Prostate Cancer × Blood Specimen Collection × Clear all
NCT03247010 2022-11-09

Bone Marrow Suppression and Recovery During Radionuclide Treatment

Rigshospitalet, Denmark

Completed
68 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡